To elucidate the role of germ cells in the regulation of inhibin B secretion, serum inhibin B levels in prepubertal boys and adult men whom had a concurrent testicular biopsy showing either normal or impaired testicular function were compared. In addition, by immunohistochemistry the cellular localization of the two subunits of inhibin B (␣ and ␤B) were examined in adult testicular tissue with normal spermatogenesis, spermatogenic arrest, or Sertoli cell only tubules (SCO) as well as in normal testicular tissue from an infant and a prepubertal boy. Adult men with testicular biopsy showing normal spermatogenesis (n ϭ 8) or spermatogenic arrest (n ϭ 5) had median inhibin B levels of 148 pg/mL (range, 37-463 pg/mL) and 68 pg/mL (range, 29 -186 pg/mL), respectively, corresponding to normal or nearnormal levels of our reference population (165 and 31-443 pg/mL; n ϭ 358). Men with SCO (n ϭ 9) had undetectable or barely detectable (n ϭ 1) serum levels of inhibin B. In contrast to adults, prepubertal boys with SCO (n ϭ 12) all had measurable serum inhibin B levels that corresponded to our previously determined normal range in healthy prepubertal boys (n ϭ 114). However, in postpubertal samples from the same SCO boys, inhibin B levels were undetectable as in the adult SCO men. Intense inhibin ␣-subunit immunostaining was evident in Sertoli cells in both prepubertal and adult testes. In the prepubertal testis, positive immunostaining for the ␤B-subunit was observed in Sertoli cells. In the adult testis, intense immunostaining for the ␤B-subunit was evident in germ cells from the pachytene spermatocyte to early spermatid stages and to a lesser degree in Leydig cells, but not in Sertoli cells or other stages of germ cells. Thus, surprisingly, in adult men the two subunits constituting inhibin B were expressed by different cell types. We speculate that during puberty Sertoli cell maturation induces a change in inhibin subunit expression. Thus, immature Sertoli cells express both ␣ and ␤B inhibin subunits, whereas fully differentiated Sertoli cells only express the ␣-subunit. The correlation in adult men between serum inhibin B levels and spermatogenesis may be due to the fact that inhibin B in adult men is possibly a joint product of Sertoli cells and germ cells, including the stages from pachytene spermatocytes to early spermatids. (J Clin Endocrinol Metab 83: [4451][4452][4453][4454][4455][4456][4457][4458] 1998) T HE GONADAL peptide hormone inhibin, which exerts negative feedback regulation of pituitary production and secretion of FSH, exists in two principal bioactive forms: the inhibin A dimer, consisting of an ␣-subunit and a ␤A-subunit, and the inhibin B dimer, consisting of an ␣-subunit and a ␤B-subunit (1). The subunits are covalently linked by a disulfide bond. By the implementation of a new immunoassay format that made it possible to measure these two bioactive inhibin forms specifically, it has been shown that inhibin B is the principal circulating bioactive inhibin form in men (2). Activins are structurally related dimers that are composed of two ␤-subunits and that can stimulate FSH release. Inhibin B is presumed to be produced primarily by the Sertoli cells of the testis based on in vitro studies (3-6) and the localization of inhibin subunit peptide and messenger ribonucleic acid in testicular tissue from rats (7-9), primates (10), and humans (9) by immunohistochemistry and in situ hybridization. However, the regulation of inhibin B secretion is still largely unknown. Studies of the role of gonadotropins or androgens in inhibin regulation are equivocal. Several studies indicate that the presence of specific germ cell types may stimulate the production and secretion of inhibin as shown in the rat (11-14) and indicated in men with impaired spermatogenesis, who generally have very low or undetectable serum inhibin B levels (15). On the other hand, we have recently shown that prepubertal boys, who do not have spermatogenesis and therefore lack the relevant germ cell types, secrete inhibin B in readily measurable levels (16, 17) . To further elucidate the role of germinal cells in the regulation of inhibin B secretion we measured serum inhibin B levels in men with either normal ongoing spermatogenesis, spermatogenic arrest, or Sertoli cell only syndrome (SCO) based on a testicular biopsy. In addition, we measured serum inhibin B levels in boys and adolescents previously treated for acute lymphoblastic leukemia (ALL), some of whom became SCO as a result of the treatment. The expression and cellular localization of inhibin ␣-and ␤B-subunits were investigated using immunohistochemistry in testicular biopsies from adult men with normal or abnormal spermatogenesis and from prepubertal boys.
T HE GONADAL peptide hormone inhibin, which exerts negative feedback regulation of pituitary production and secretion of FSH, exists in two principal bioactive forms: the inhibin A dimer, consisting of an ␣-subunit and a ␤A-subunit, and the inhibin B dimer, consisting of an ␣-subunit and a ␤B-subunit (1). The subunits are covalently linked by a disulfide bond. By the implementation of a new immunoassay format that made it possible to measure these two bioactive inhibin forms specifically, it has been shown that inhibin B is the principal circulating bioactive inhibin form in men (2) . Activins are structurally related dimers that are composed of two ␤-subunits and that can stimulate FSH release. Inhibin B is presumed to be produced primarily by the Sertoli cells of the testis based on in vitro studies (3) (4) (5) (6) and the localization of inhibin subunit peptide and messenger ribonucleic acid in testicular tissue from rats (7) (8) (9) , primates (10) , and humans (9) by immunohistochemistry and in situ hybridization. However, the regulation of inhibin B secretion is still largely unknown. Studies of the role of gonadotropins or androgens in inhibin regulation are equivocal. Several studies indicate that the presence of specific germ cell types may stimulate the production and secretion of inhibin as shown in the rat (11) (12) (13) (14) and indicated in men with impaired spermatogenesis, who generally have very low or undetectable serum inhibin B levels (15) . On the other hand, we have recently shown that prepubertal boys, who do not have spermatogenesis and therefore lack the relevant germ cell types, secrete inhibin B in readily measurable levels (16, 17) . To further elucidate the role of germinal cells in the regulation of inhibin B secretion we measured serum inhibin B levels in men with either normal ongoing spermatogenesis, spermatogenic arrest, or Sertoli cell only syndrome (SCO) based on a testicular biopsy. In addition, we measured serum inhibin B levels in boys and adolescents previously treated for acute lymphoblastic leukemia (ALL), some of whom became SCO as a result of the treatment. The expression and cellular localization of inhibin ␣-and ␤B-subunits were investigated using immunohistochemistry in testicular biopsies from adult men with normal or abnormal spermatogenesis and from prepubertal boys.
Based on our observations, we hypothesize that inhibin B in adult men may be produced by Sertoli cells and spermatocytes in collaboration.
Subjects and Methods Subjects
Prepubertal boys. Simultaneous testicular biopsies and blood samples were available from 34 boys previously treated for ALL, who had testicular biopsy performed for screening for lymphoblastic infiltration. Of these boys, 12 acquired a SCO pattern as a consequence of their treatment, 13 boys had testes with normal numbers of germinal cells, and 9 boys had testes with reduced numbers of germinal cells after termination of treatment for ALL. From 17 boys, longitudinal blood samples and testicular biopsies were available, and from 6 of these boys postpubertal blood samples were also available. For immunocytochemistry, testicular tissue was obtained at autopsy from 2 boys, aged 4.5 months and 7 yr, who had died in sudden accidents.
Adult men. Concurrent testicular biopsies and blood samples were obtained from men referred to our clinic for infertility and from testicular cancer patients who had biopsy performed as screening for carcinoma in situ in the contralateral testis. Based on the testicular biopsy and semen parameters, men were grouped according to the presence of normal spermatogenesis (n ϭ 8), spermatogenic arrest (n ϭ 5), or SCO syndrome (n ϭ 9). The men with normal spermatogenesis included five men with obstruction of the efferent ducts, two testicular cancer patients with one remaining normal testis after unilateral orchidectomy, and one patient with normal spermatogenesis in one testis and spermatogenic arrest of the other. Men with spermatogenic arrest were defined as having bilateral spermatogenic arrest and azoospermia. The SCO men were defined as having SCO and azoospermia and included four men with idiopathic bilateral SCO and five unilaterally orchidectomized men with SCO in the remaining testis due to irradiation for carcinoma in situ.
Serum samples and testicular biopsies
Serum was separated after clotting and was stored at Ϫ20 C until hormone measurements. Adult serum samples were measured within a few weeks from the time of sampling, whereas the time of storage of serum samples from ALL treated boys varied from 15 yr to a few months. Serum inhibin B was measured in an enzyme immunometric assay, previously described (18) . This assay is specific for the bioactive inhibin B dimer (␣-␤B). The sensitivity of the inhibin B assay was 18 pg/mL, and the intra-and interassay coefficients of variation were less than 12% and less than 17%, respectively. Testicular biopsies of approximately 2 ϫ 2 mm (boys) or 3 ϫ 3 mm (adult men) were obtained by open surgery and fixed in Stieve's fixative. For evaluation of spermatogenic status, slides were stained with hematoxylin-eosin before evaluation by light microscopy.
Testicular biopsy and blood sampling in boys treated for ALL as screening for testicular relapse was approved by the local ethical board. In the adult subjects, testicular biopsies and blood samples were performed as part of a clinical routine evaluation. The patients had given informed consent to the procedures.
Immunohistochemistry
Sections (4 m) were mounted on SuperFrost Plus slides (Menzel, Braunschweig, Germany) and dried overnight at 50 C. Before incubation with primary antibody, sections were dewaxed, rehydrated in graded ethanol, and washed in water and 0.05 mol/L Tris-HCl (pH 7.4) and 0.15 mol/L NaCl (TBS). Sections were subjected to antigen retrieval by microwaving in 0.01 mol/L citrate buffer (pH 5.5) on full power (750 watts) for 2 min and on 40% power for an additional 18 min. Sections were allowed to cool at room temperature for 20 min before being washed for 5 min in TBS and subsequently incubated in 1% H 2 O 2 in TBS for 30 min to block endogenous peroxidase. Purified monoclonal antibodies directed against ␣-subunit (19) (code R1) were used at a concentration of 2 g/mL, and two different antibodies against the ␤B-subunit (18) (code C5 and 12/13) were used at concentrations of 25 and 5 g/mL, respectively. The C5 and 12/13 antibodies directed against the ␤B-subunit had 0.5-1% cross-reactivity with the ␤A-subunit (18) . Primary antibodies were diluted in TBS and incubated on sections in a humid chamber overnight at 4 C. The following day sections were washed three times in TBS (3 min/wash), incubated with biotinylated goat antimouse Igs (Zymed histostain kit, Zymed Laboratories, Inc., San Francisco, CA) for 30 min, and then washed again three times in TBS. For detection of bound antibodies, sections were subsequently incubated with peroxidase-conjugated streptavidin-biotin complex (Zymed Histostain) for 30 min, followed by washing three times in TBS. Color was developed in an aminoethyl carbazole substrate solution (Zymed Histostain kit). After 6 -10 min of color development, sections were washed in tap water, counterstained with hematoxylin, and mounted in glycerol vinyl alcohol (Zymed Laboratories, Inc.). On sections from prepubertal testes an alternative immunostaining procedure was also used. In the alternative procedure the second layer of antibody was exchanged with unlabeled rabbit antimouse antibody (Dako Corp., Glostrup, Denmark) diluted 1:50 in TBS, and the third layer was exchanged with alkaline phosphatase-antialkaline phosphatase complex (Dako Corp.) diluted 1:25 in TBS. After a final wash in 0.05 mol/L Tris-HCl (pH 8.7), color was developed in a new fuchsin substrate solution (Sigma, St. Louis, MO). The specificity of the antibodies was controlled by using normal mouse serum instead of primary antibodies and by preabsorbing the antibodies with the corresponding peptide.
Statistics
Differences in inhibin B levels among men with normal spermatogenesis, spermatogenic arrest, and SCO were tested by the Mann-Whitney U test. The influence of storage on serum inhibin B levels was tested by linear regression on data that were square root transformed to obtain a good approximation to the normal distribution.
Results

Serum inhibin B levels in boys and adult men
The median and range of serum inhibin B levels within the different groups are summarized in Table 1 . For comparison, serum inhibin B levels in a normal population of 114 prepubertal boys and 358 adult men, which have been described previously (17) , are also included in the table.
Serum inhibin B levels in samples from boys treated for ALL with either normal testicular pattern or SCO are plotted according to age in relation to normal ranges in Fig. 1 . Sera from boys treated for ALL had been stored at Ϫ20 C from a few weeks up to 15.3 yr (median, 4.8 yr) before being analyzed for inhibin B. Because of the large variation in length a Normal reference ranges were previously published (17) .
of storage, the long term storage stability of inhibin B had to be considered. There was no time trend in prepubertal inhibin B levels when plotted according to storage time (r 2 ϭ 0.005; P ϭ 0.638), indicating that inhibin B was relatively stable during long term storage. Furthermore, serum inhibin B levels in prepubertal boys treated for ALL with normal testis pattern were all within the normal range for prepubertal boys, as were the levels in prepubertal boys with SCO. In all postpubertal samples from boys who acquired a SCO pattern, serum inhibin B levels were undetectable (Fig. 1) .
Serum inhibin B levels in the group of men with testicular biopsies showing normal spermatogenesis, including the three men who only had one testis with normal spermatogenesis, were all within the normal range for adult men. Serum inhibin B levels in the group of men with spermatogenic arrest were in the low normal range. However, there was no statistically significant difference between the levels in men with normal spermatogenesis and those in men with spermatogenic arrest (by Mann-Whitney U test). In contrast, all men with SCO, except one, had unmeasurable serum levels of inhibin B.
Expression of inhibin B subunits in human prepubertal and adult testes
In prepubertal testes, intense positive immunostaining for inhibin ␣-subunit was observed that was localized to Sertoli and interstitial cells (Fig. 2A) . Positive immunostaining for inhibin ␤B-subunit was also observed in Sertoli cells of prepubertal testes (Fig. 2B) . In adult testes with ongoing spermatogenesis, positive immunostaining for inhibin ␣-subunit was observed in both Sertoli cells and Leydig cells (Fig. 3, A  and B) . A similar ␣-subunit immunostaining pattern was observed in testes with spermatogenic arrest (Fig. 4A ) and in testes with SCO (Fig. 4B) . In adult testes with normal spermatogenesis and with spermatogenic arrest, intense immunostaining for the inhibin ␤B-subunit was located in germ cells from pachytene spermatocytes to round spermatids (Figs. 3, C and D, and 4C ). An identical staining pattern was observed using two different monoclonal anti-␤B antibodies. In contrast, no staining for the inhibin ␤B-subunit was observed in Sertoli cells; spermatogonia; preleptotene, leptotene, or zygotene spermatocytes; or late spermatids (from types Sb-Sd). However, Leydig cells were also positive for ␤B-subunit immunostaining. In adult testes with SCO, no intratubular immunostaining for the ␤B-subunit was observed (Fig. 4D) . Occasionally, faint ␤B-subunit immunostaining was observed in a few Leydig cells, but, in general, Leydig cells were also negative for ␤B-subunit staining in SCO testes.
Discussion
In our study in which serum inhibin B levels could be directly correlated to the testicular status based on a concurrent testicular biopsy, we have demonstrated that the regulation of inhibin B secretion changes during puberty. Whereas serum inhibin B levels in prepubertal boys were independent of the presence of germinal cells, serum inhibin B levels in postpubertal men were closely related to the presence of germinal cells from pachytene spermatocytes to early spermatids. In the rat, inhibin production has also been correlated to the presence of certain germ cell types (11) (12) (13) (14) , although in this species inhibin production, as measured in an ␣-subunit assay, was highest in the presence of late spermatids.
Human adult serum inhibin B levels, however, were not dependent on complete spermatogenesis, as serum inhibin B levels were measurable in all five men with bilateral spermatogenic arrest at the spermatocyte level, although the inhibin B levels tended to be lower than those observed in a normal male population, including men with documented complete spermatogenesis. Furthermore, levels of serum inhibin B in men with only one normal functioning testis were well within the normal range, indicating that the remaining testis after unilateral orchidectomy may be able to compensate for the missing testis with respect to inhibin B secretion.
The regulation of inhibin B secretion in prepubertal boys is not clear. The localization of both ␣-and ␤B-subunits to interstitial and Sertoli cells in the prepubertal human testis observed in this study is in agreement with previous findings in the rat (8, 9) and human (9) . We recently showed that serum inhibin B levels are temporarily highly elevated postnatally, presumably as a consequence of the temporary activation of the pituitary shortly after birth (17) , as also shown previously (20) , indicating that inhibin B secretion in the newborn is under the influence of gonadotropins. Later in childhood, gonadotropin levels are low, but perhaps sufficient to sustain the readily measurable serum levels of inhibin B observed throughout childhood (16) . Thus, serum inhibin B levels in hypogonadotropic boys are in the low range of healthy boys (21) , although this may be due to a reduced number of Sertoli cells rather than to decreased inhibin B production caused by low FSH levels. Compared to the staining intensity observed for the ␤B-subunit in the adult testis, the staining in prepubertal testes was relatively weak. This was also true in the testis from a boy aged 4.5 months, although this is an age when serum inhibin B levels is known to be increased above adult levels (17) .
Several studies showing localization of the inhibin ␣-subunit in human testis exist that, in general, agree on the localization of this subunit to the Sertoli cells and interstitial/ Leydig cells in adult testes (22) (23) (24) (25) . Inhibin ␤B-subunit expression has previously been localized to Sertoli cells in the adult rat (8, 9) and monkey (10) . Recently, a study on the immunolocalization of the inhibin/activin ␤B-subunit in the adult human testis using the same antibodies as in our present study was published that showed colocalization of the ␣-and ␤B-subunits in the Sertoli cells (26) . In contrast to these findings, we found that the ␤B-subunit was localized to pachytene spermatocytes and round spermatids as well as to Leydig cells, whereas the ␣-subunit was localized to Sertoli cells and Leydig cells in the adult human testis. We do not know the reason for this discrepancy, but it may be due to differences in the fixation and processing of the tissue. The facts that we were able to eliminate our ␤B-subunit staining pattern by preabsorbing the antibody with a ␤B peptide, that the staining pattern was highly reproducible in several different tissue section from different men, and that our ␤B-subunit staining was restricted to selected germ cell types with no or negligible background staining of other cell types strongly indicate that our ␤B-subunit staining was specific. However, as both subunits are needed to produce inhibin B, our findings raises the question of where circulating inhibin B is produced in the adult human testis. As both subunits are present in Leydig cells, it cannot be excluded that these cells contribute to the circulating levels of inhibin B. However, studies in rats have shown that the major route via which inhibin reaches the bloodstream is through secretion into the seminiferous tubular fluid, thus supporting the idea of an intratubular production of inhibin (27) . Alternatively, it may be speculated that the Sertoli cells express the inhibin ␤B-subunit at levels below the sensitivity of our immunohistochemistry. The site of dimerization of inhibin subunits is not known. By electron microscopy, evidence of transfer of inhibin ␣-subunit from Sertoli cells to spermatocytes has been reported in the human testis (24) . However, although inhibin subunit dimerization may take place intracellularly in the spermatocytes, it could also theoretically take place extracellularly. Creation of a disulfide bond from the sulfhydryl groups of two cystein residues is a passive reaction that does not require energy and that takes place in a nonreducing environment, such as in the endoplasmic reticulum, Golgi, coated vesicles, or even extracellular fluid. Manson et al. have shown that the propeptide sequences present in the ␤-subunit precursors are necessary for dimerization, presumably by providing the proper configuration for the involved cystein residues to be exposed (28, 29) . However, several studies have shown that a high proportion of the inhibin forms in plasma consist of unprocessed or partly processed precursor dimers (30, 31) , indicating that the structural elements necessary for dimerization of subunits are still present after secretion. Further processing of inhibin/activin precursors into the bioactive hormone by cleavage of the proprotein region can also take place extracellularly (32) .
We speculate that in the adult human testis, inhibin B may be a joint product of Sertoli cells and spermatocytes, and hence the change in localization of the ␤B subunit during maturation may explain why serum inhibin B levels are germ cell dependent in the mature testis and not in the immature testis in man. Furthermore, our hypothesis that inhibin subunit dimerization and processing may take place postsecretionally may explain the abundance of non-or partly processed as well as monomeric forms of inhibin in serum. The five men with spermatogenic arrest who were included in this study all had spermatogenic progress that included the level of pachytene spermatocytes and all had measurable serum inhibin B levels. The somewhat lower serum inhibin B levels in these men could be explained by the fact that, in general, they have fewer spermatocytes beyond the pachytene stage and no spermatids. If, as we believe, ␤B-subunit expression by pachytene spermatocytes and round spermatids correlates with serum inhibin B levels, we would expect men with spermatogenic arrest at a level before the pachytene stage to have very low or unmeasurable serum inhibin B levels.
␤B-subunits may also bind together as homodimers to make activin B. Thus, the expression of the ␤B-subunit by certain stages of spermatocytes may not have anything to do with inhibin B, but, rather, may imply expression of activin B by these types of spermatocytes. As no activin B dimerspecific antibody is available to our knowledge, it is not possible by immunohistochemistry or in situ hybridization to distinguish whether the observed ␤B peptide expression in spermatocytes is present as free ␤B-subunits or activin B dimers. To our knowledge no specific activin B immunoassays are presently available, but development of such an assay would facilitate the specific quantitative measurement of activin B in enriched spermatocyte preparations and thus aid in solving this question.
In conclusion, during pubertal maturation of the human male, testicular inhibin B production becomes germ cell dependent. This change in inhibin B regulation may be explained by a maturational change in the localization of expression of the inhibin ␤B-subunit from the Sertoli cells to specific germ cell stages in the spermatogenic process, namely to cells from the pachytene spermatocyte to round spermatid stages. Our suggestions that inhibin B is a joint product, and that the subunits of which may originate from different cell types propose to our knowledge a new concept in the regulation of peptide hormone and growth factor expression. This maturational change in the production and regulation of inhibin B levels thus provides a close link between serum inhibin B levels (and thus FSH feedback regulation) and spermatogenesis.
